Published April 28, 2026
| Version v1
Preprint
Open
Withanoside IV from Ayurvedic Ashwagandha for Cognitive Enhancement in Tetrasomy X
Description
Withanoside IV crosses the blood-brain barrier and selectively modulates GABA-A receptor α5 subunit expression while enhancing BDNF-TrkB signaling. In tetrasomy X patients with intellectual disability, this dual mechanism addresses both the GABAergic imbalance from excess X-linked genes and promotes synaptic plasticity through neurotrophin pathway activation.
Notes
Files
hypothesis.json
Files
(367 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:f821ff209d59fcb36e8fbe87c1ab0124
|
367 Bytes | Preview Download |